rediff.com
e.g. Tata motors, Reliance MF, 500570
LINK PHARMA CHEM LTD. - Board Meeting Outcome for Reclassification Was Subject To The Approval Of The Other Regulatory Authorities, In Terms Of Regulation 31A Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 And Amendments Thereof.
Download announcement < Back
25 Jul 2024
Outcome for board meeting in the matter of Reclassification was subject to the approval of the other regulatory authorities, in terms of Regulation 31A of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and amendments thereof.
View all announcements for LINK PHARMA CHEM LTD. Source: BSE India